The MR-PET workflow in Mirada’s XD3 oncology software combines tri-modal registration of MR with CT-PET to present a combined diagnostic picture for clinical decision making.
Mirada worked with interdisciplinary clinical specialists to ensure those key indications and workflows are supported by XD3.
With XD3, users can load all MRI sequences with CT-PET and use validated deformable registration to display fused PET with multiple MR sequences and, if required, an additional multislice CT scan.
Mirada CEO Hugh Bettesworth said the majority of clinicians who will not be using hybrid equipment, Mirada XD3 will provide software fusion of their existing reimbursed MRI and PET or CT-PET scans.
Mirada will also showcase software which enables presentations to be used at tumor boards.
Individual patient cases can be sent directly from the XD3 reading application in only a few clicks via Mirada’s Casemeeting product.
